As a consequence of ageing, the number of prescribed medications for people living with HIV is increasing. Concomitant use of different drugs and their potential interactions may increase anticholinergic exposure and escalate the risk for side effects. We conducted an analysis in our cohort of people living with HIV over 50 years of age to evaluate the overall anticholinergic risk, as it is useful to identify, prevent, and manage increased side effect risks.
a‘Magna Graecia University’, Catanzaro, Italy
bChelsea and Westminster Hospital NHS Foundation Trust
cImperial College London, London, UK.
Correspondence to Dr Maria Mazzitelli, MD, Magna Graecia University, Catanzaro, Italy; Chelsea and Westminster Hospital, London, UK. E-mail: firstname.lastname@example.org
Received 26 July, 2019
Revised 22 August, 2019
Accepted 2 September, 2019